Evidence map›Paper›PMID 25525609›Full record

ArticleJournal of diabetes research2014

Glyoxylate, a new marker metabolite of type 2 diabetes.

Victoria J Nikiforova, Pieter Giesbertz, Jan Wiemer, Bianca Bethan, Ralf Looser, Volker Liebenberg, Patricia Ruiz Noppinger, Hannelore Daniel, Dietrich Rein

Registry-linked trialOpen access · goldAbstract read
In one paragraph

Article in Journal of diabetes research, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT06959043 (Therapeutic Strategies for Type 2 Diabetes Based on Lifestyle Changes), which is not on this map. Cited by 35 papers.

0numbers the graph read from it
0cells of the map it votes in
35citing papers in PubMed
3.8field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT06959043 narecruitingnot on this mapstarted 2022, after this paper: background citation

Therapeutic Strategies for Type 2 Diabetes Based on Lifestyle Changes: Plant-based Diet and Physical Exercise

TypeinterventionalSponsorMaria Elizabeth Rossi da SilvaRan2022 to 2026Enrolled60ConditionsType 2 Diabetes Mellitus (T2DM), Insulin Resistance, Inflamation, Gut MicrobiomesArmsProbiotic Supplementation, Placebo Administration
3 · Its place in the literature

Who cites it

35 citing papers in PubMed, 66 citations in OpenAlex.

  1. Article
  2. The prairie vole gut-brain-microbiota-axis: a narrative review.Gut microbiome (Cambridge, England) · 2026
    Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Application of Metabolomics and Traditional Chinese Medicine for Type 2 Diabetes Mellitus Treatment.Diabetes, metabolic syndrome and obesity : targets and therapy · 2023
    Review
  16. Article
  17. Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 4 institutions in 2 countries.

Victoria J NikiforovaMetanomics Health GmbH, 10589 Berlin, Germany ; Timiryazev Institute of Plant Physiology, Russian Academy of Sciences, Moscow 127276, Russia.
Pieter GiesbertzZIEL Research Center for Nutrition and Food Sciences, Biochemistry Unit, Technische Universität München, 85354 Freising, Germany.
Jan Wiemermetanomics GmbH, 10589 Berlin, Germany ; Thermo Fisher Scientific, Clinical Diagnostics, BRAHMS GmbH, 16761 Hennigsdorf, Germany.
Bianca Bethanmetanomics GmbH, 10589 Berlin, Germany.
Ralf Loosermetanomics GmbH, 10589 Berlin, Germany.
Volker LiebenbergMetanomics Health GmbH, 10589 Berlin, Germany ; Thermo Fisher Scientific, Clinical Diagnostics, BRAHMS GmbH, 16761 Hennigsdorf, Germany.
Patricia Ruiz NoppingerMetanomics Health GmbH, 10589 Berlin, Germany ; Medizinische Fakultät Carl Gustav Carus, Technische Universität Dresden, 01307 Dresden, Germany.
Hannelore DanielZIEL Research Center for Nutrition and Food Sciences, Biochemistry Unit, Technische Universität München, 85354 Freising, Germany.
Dietrich ReinMetanomics Health GmbH, 10589 Berlin, Germany.
Technical University of Munich · DEThermo Fisher Scientific (Germany) · DETimiryazev Institute of Plant Physiology · RUTU Dresden · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Type 2 diabetes (T2D) is characterized by a variety of metabolic impairments that are closely linked to nonenzymatic glycation reactions of proteins and peptides resulting in advanced glycation end-products (AGEs). Reactive aldehydes derived from sugars play an important role in the generation of AGEs. Using metabolite profiling to characterize human plasma from diabetic versus nondiabetic subjects we observed in a recent study that the reactive aldehyde glyoxylate was increased before high levels of plasma glucose, typical for a diabetic condition, could be measured. Following this observation, we explored the relevance of increased glyoxylate in diabetic subjects and in diabetic C57BLKS/J-Lepr (db/db (-/-)) mice in the pathophysiology of diabetes. A retrospective study using samples of long-term blood donors revealed that glyoxylate levels unlike glucose levels became significantly elevated up to 3 years prior to diabetes diagnosis (difference to control P = 0.034). Elevated glyoxylate levels impact on newly identified mechanisms linking hyperglycemia and AGE production with diabetes-associated complications such as diabetic nephropathy. Glyoxylate in its metabolic network may serve as an early marker in diabetes diagnosis with predictive qualities for associated complications and as potential to guide the development of new antidiabetic therapies.

Indexed as

AnimalsBiomarkersDiabetes Mellitus, Type 2Disease Models, AnimalFastingGenotypeGlyoxylatesHumansMaleMetabolomicsMice, Inbred C57BLMuscle, SkeletalPhenotypePredictive Value of TestsProspective StudiesRetrospective StudiesBiomarkersGlyoxylatesglyoxylic acid

Identifiers

PMID25525609
PMCPMC4265698
OpenAlexW2126108551

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.